Pathophysiology and management of glaucoma and ocular hypertension related to trauma.
Razeghinejad R, Lin MM, Lee D, Katz LJ, Myers JS.
Surv Ophthalmol. 2020 Sep-Oct;65(5):530-547. doi: 10.1016/j.survophthal.2020.02.003. Epub 2020 Feb 11.
OCULAR HYPERTENSION AND GLAUCOMA FOLLOWING VITRECTOMY: A Systematic Review.
Miele A, Govetto A, Fumagalli C, Donati S, Biagini I, Azzolini C, Rizzo S, Virgili G.
Retina. 2018 May;38(5):883-890. doi: 10.1097/IAE.0000000000001651.
Ocular hypertension: an approach to assessment and management.
Boey PY, Mansberger SL.
Can J Ophthalmol. 2014 Dec;49(6):489-96. doi: 10.1016/j.jcjo.2014.06.013.
Ocular Hypertension Treatment Study (OHTS) commentary.
Lee BL, Wilson MR; Ocular Hypertension Treatment Study (OHTS).
Curr Opin Ophthalmol. 2003 Apr;14(2):74-7. doi: 10.1097/00055735-200304000-00003.
Uveitic Ocular Hypertension and Glaucoma.
Cunningham ET Jr, Zierhut M.
Ocul Immunol Inflamm. 2017 Dec;25(6):737-739. doi: 10.1080/09273948.2017.1415077.
[Ocular hypertension and optic neuropathies secondary to dysthyroid orbitopathy: Review of the literature].
Bellot L, Graber M, Laurent C, Mouriaux F.
J Fr Ophtalmol. 2021 Oct;44(8):1256-1261. doi: 10.1016/j.jfo.2021.01.026. Epub 2021 Jul 21.
Glucocorticoid therapy and ocular hypertension.
Dibas A, Yorio T.
Eur J Pharmacol. 2016 Sep 15;787:57-71. doi: 10.1016/j.ejphar.2016.06.018. Epub 2016 Jul 5.
Current management of uveitis-associated ocular hypertension and glaucoma.
Kesav N, Palestine AG, Kahook MY, Pantcheva MB.
Surv Ophthalmol. 2020 Jul-Aug;65(4):397-407. doi: 10.1016/j.survophthal.2019.12.003. Epub 2019 Dec 6.
[Ocular hypertension after intravitreal injection: Screening and management].
Poli M, Denis P, Dot C, Nordmann JP.
J Fr Ophtalmol. 2017 Mar;40(3):e77-e82. doi: 10.1016/j.jfo.2017.01.003. Epub 2017 Mar 9.
Ocular hypertension in Axenfeld-Rieger Syndrome.
Espinosa-Barberi G, Galván González JF, Antón A.
Rom J Ophthalmol. 2020 Oct-Dec;64(4):455-458. doi: 10.22336/rjo.2020.70.
